INmune Bio OverviewINmune Bio EBIT
EBIT (Earnings Before Interest and Taxes) analysis for INMB.
Quarterly EBIT
-$5.81M
↑ 41.32% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$13.38M
↑ 67.58% YoY
Trailing 12 months ending Mar 31, 2026
INmune Bio OverviewEBIT (Earnings Before Interest and Taxes) analysis for INMB.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026